Delivery Order SPE2DR25D2022-SPE2DR26F2ZMC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Furosemide 100 mg/10 mL vials with a ceiling value of $1,042.59 and an ultimate completion date of September 10, 2025. This competitive award, which utilized no set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,557.68 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Furosemide 20 mg/2 mL vials (2 mL quantity). This firm fixed price delivery order, with an ultimate completion date of September 22, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Furosemide 20 mg/2 mL vials totaling $1,762.83 under a firm fixed-price contract. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency Troop Support Medical awarded a $637.44 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/10 ml vials of furosemide. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA Troop Support and other Department of Defense customers. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania between July 28 and July...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $109.70 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561577977 units of the pharmaceutical product Furosemide 100 mg/10 ml vial, with each vial containing 10 ml of solution. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 24, 2023 through July 25, 2023. No major subcontractors or...
- This is a delivery order contract awarded by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $4,233.31 firm fixed price contract is for the delivery of Furosemide 20mg/2ml medication in 25-count packages. The contract does not have a set-aside designation and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- The Defense Logistics Agency Troop Support Medical awarded a $54,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/10 ml vials of furosemide. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA Troop Support and other Department of Defense customers. Performance will take place in Conshohocken, Pennsylvania over a period of four days from August 4-7, 2023. No...
- The Defense Logistics Agency awarded a $2,947.44 delivery order to AmerisourceBergen Drug Corp for SYFOVRE 15 mg/0.1 ml vials on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bumetanide 2.5 mg/10 ml vials on September 12, 2025, with a ceiling value of $1,429.78 and ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $21,388.96. This non-set-aside, firm fixed price delivery order is scheduled for completion by December 4, 2025, with fulfillment based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- SPE2DR25D2022Indefinite Delivery Contract
- SPE2DR25D2022-SPE2DR26F2ZMCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Furosemide 100 mg/10 ml vials with a ceiling value of $2,087.44. This non-competitive delivery order represents a firm fixed-price contract with an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order supports the Defense Logistics Agency's Medical Supply Chain, which maintains pharmaceutical inventory for military and federal healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, leverages its comprehensive IDC vehicle to fulfill specialized medical supply needs across multiple therapeutic domains. The Furosemide supply under this order contributes to the agency's broader mission of ensuring adequate pharmaceutical resources for defense health programs and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/10/25 |